Gilead is a research based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. Gilead’s antiviral treatment, developed with decades of antiviral expertise, became the first approved treatment option for COVID-19 in the European Union. Gilead provided all current supply of the antiviral treatment at no cost throughout the world, including Turkey.
Gilead, also provided 1.3 million Turkish Liras of grants to patient and physician associations to support these organizations during COVID-19 pandemic. Moreover, 2 million Turkish Liras donated to Health Institutes of Turkey for the provision of materials and equipment to COVID-19 testing and screening centers.